ST6GAL1 and ovarian cancer: In conclusion, these results indicate that the disruption of B3GNT5 and the corresponding loss of α2-6 sialylation on N-glycans appear due to the preferential silencing of ST6GAL1 gene expression in both ovarian cancer cell lines, IGROV1 and SKOV3 (Fig. 6).